Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Gold Trust (IAU) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance

iShares Gold TrustTrade
Iovance Biotherapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares Gold Trust vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? iShares Gold Trust trades at $78.88 (market cap $61.51B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.8 (market cap $6.04B). The key difference: iShares Gold Trust is far larger — about 10.2× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, iShares Gold Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Gold Trust for 49 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.

IAUIOVA
Market Cap
$61.51B$6.04B
Volume
3,206,72914,805,993
Sector
Commodities - Metals/AgricultureHealth
52-Week High
$101.57$14.82
52-Week Low
$74.21$1.81
Typical Hold Time
49 Days0 Days
Enterprise Value
—$5.97B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Gold Trust

IAU stock trades at $78.88, up 2.36% with a $1.82 daily gain, though technical indicators show a bearish trend with 17 sell signals versus 2 buy signals. The stock faces pressure from rising Treasury yields and Federal Reserve rate uncertainty, with support levels at $76-$77 and resistance at $78-$79. Recent news highlights gold's sensitivity to inflation data and interest rate expectations.

The outlook remains cautious due to macroeconomic headwinds and technical weakness. Investment opportunities exist if gold prices stabilize amid inflation concerns, but risks include persistent rate hikes and dollar strength. Monitor Fed policy and economic data for directional cues.

Iovance Biotherapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IAU
88% Buy12% Sell
Avg holding period · 49 Days
IOVA
51% Buy49% Sell
Avg holding period · 0 Days

About iShares Gold Trust

IAU is a physically backed ETF that seeks to reflect the performance of the price of gold. It provides a convenient and liquid way for investors to include gold in their portfolios as a potential hedge.

Read more on IAU →

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →